News

Newsletter

2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA

ANVISA’s new Regulatory Agenda 2024-2025 (RA 24/25) was approved and published on the Official Gazette on December 18th. The Joint Ordinance No. 1.409 of 2023 approved the Regulatory Agenda (RA) which covers the priorities for the 2024-2025 biennium.

The Regulatory Agenda is a planning instrument for the normative activities of the Agency. It presents several priority topics to be regulated by ANVISA whilst its validity. Therefore, such Agenda sheds light on the themes do to be improved by regulatory means for the next two years in Brazil.

Social participation alongside the National Sanitary Surveillance System (Sistema Nacional de Vigilância Sanitária – SNVS) was crucial to the construction of the RA 24/25. There were 1.449 contributions received by ANVISA’s Public Consultancy.

The just approved agenda covers 172 regulatory themes, divided into 16 macro themes. Topics that received most regulatory demands include Drugs with 45 themes, Food with 34 themes and cross-sectional issues with 23 themes. 

106 out of the 172 themes pertaining the new agenda are related to the subject matters already announced on the 2021-2023 agenda. 66 themes are new and unrelated to the previous agenda. 

The Regulatory Agenda 2024-2025 guarantees visibility and transparency for the normative regulatory activities by ANVISA. It will come into effect on January 2nd, 2024.

For more information regarding ANVISA, please do not hesitate to contact us by email: regulatorio@kasznarleonardos.com.

Back

Last related news

April 11, 2024

Ministry of Finance Defines Regulatory Agenda for the Betting Market

In another step towards the realization and consolidation of the regulations provided for by the New Betting Law (Law 14.790/2023), the Ministry Ministry of Finance Defines Regulatory Agenda for the Betting Market

Ler notícia

March 21, 2024

European Union Artificial Intelligence Act is approved by the Parliament

On Wednesday (March 13th, 2024), the AI Act – European regulation that aims to lay down harmonized rules on artificial intelligence – European Union Artificial Intelligence Act is approved by the Parliament

Ler notícia

February 27, 2024

Brazilian Patent and Trademarks Office (INPI) allows amendments to patent applications during the appeal phase, subject to new criteria

As announced by our firm in our Newsletter No. 67 of December 15, 2023, a position of the INPI’s Federal Attorney’s Office, Brazilian Patent and Trademarks Office (INPI) allows amendments to patent applications during the appeal phase, subject to new criteria

Ler notícia
plugins premium WordPress